MENU
+Compare
GNPX
Stock ticker: NASDAQ
AS OF
Jul 10, 04:59 PM (EDT)
Price
$0.29
Change
+$0.01 (+3.57%)
Capitalization
8.21M

GNPX Genprex Forecast, Technical & Fundamental Analysis

Genprex Inc is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes... Show more

GNPX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for GNPX with price predictions
Jul 10, 2025

GNPX in upward trend: price may jump up because it broke its lower Bollinger Band on June 23, 2025

GNPX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 46 cases where GNPX's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on July 08, 2025. You may want to consider a long position or call options on GNPX as a result. In of 83 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for GNPX just turned positive on July 08, 2025. Looking at past instances where GNPX's MACD turned positive, the stock continued to rise in of 43 cases over the following month. The odds of a continued upward trend are .

GNPX moved above its 50-day moving average on July 09, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where GNPX advanced for three days, in of 207 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

The 10-day moving average for GNPX crossed bearishly below the 50-day moving average on June 26, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where GNPX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for GNPX entered a downward trend on July 02, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.182) is normal, around the industry mean (17.368). P/E Ratio (0.000) is within average values for comparable stocks, (59.372). GNPX's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.445). Dividend Yield (0.000) settles around the average of (0.041) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (273.506).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. GNPX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. GNPX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
GNPX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

GNPX is expected to report earnings to rise 1,053.85% to -300 cents per share on March 29

Genprex GNPX Stock Earnings Reports
Q4'23
Est.
$-3.00
Q1'25
Beat
by $0.60
Q4'24
Missed
by $0.39
Q3'23
Missed
by $4.50
Q2'23
Missed
by $5.07
The last earnings report on May 12 showed earnings per share of -25 cents, beating the estimate of -86 cents. With 689.52K shares outstanding, the current market capitalization sits at 8.21M.
A.I. Advisor
published General Information

General Information

a developer of molecular therapies for cancer treatment

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
3300 Bee Cave Road
Phone
+1 877 774-4679
Employees
26
Web
https://www.genprex.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HSCS5.731.36
+31.12%
HeartSciences Inc
PRME4.690.15
+3.30%
Prime Medicine
DCTH12.550.14
+1.13%
Delcath Systems
SSNC83.610.29
+0.35%
SS&C Technologies Holdings
AWR77.11-0.54
-0.70%
American States Water Company

GNPX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, GNPX has been loosely correlated with REVB. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if GNPX jumps, then REVB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GNPX
1D Price
Change %
GNPX100%
+2.76%
REVB - GNPX
48%
Loosely correlated
-0.88%
HOWL - GNPX
38%
Loosely correlated
+0.93%
APVO - GNPX
31%
Poorly correlated
-0.99%
AXON - GNPX
30%
Poorly correlated
-9.04%
TYRA - GNPX
30%
Poorly correlated
+3.33%
More